<DOC>
	<DOCNO>NCT01545713</DOCNO>
	<brief_summary>Antibody Mediated Rejection ( AMR ) major complication solid organ transplantation . The main reason AMR pre-formed , de-novo , donor specific antibody donor HLA antigen . Additional potential target antibodies MIC-A antigen antibody target express donor endothelial cell . Until recently , specific mean available test presence donor-specific endothelial cell antibody . The newly introduce XM-One AbSorber® assay allow isolate precursor endothelial cell donor peripheral blood , thus assess presence donor-specific endothelial cell antibody . XM-One AbSorber® in-vitro assay allow specific enrichment precursor endothelial cell turn promote endothelial cell specific cross match test . This assay currently use on-going Northwestern University ( NU ) research study ( STU # 00029988 ) . The preliminary result study indicate indeed patient test positive respective donor . One potential explanation observation , previously entertain , antibody cause positive cross match response actually autoimmune nature . In order rule-out potential explanation investigator would like test patient perform autologous XM-One AbSorber® assay recipient serum incubate patient ' cell ( opposed respective donor cell parental study ) . This information crucial proper analysis data obtain NU STU # 00029988 study .</brief_summary>
	<brief_title>Correlation Donor-specific Anti-endothelial Cells</brief_title>
	<detailed_description>Antibody Mediated Rejection ( AMR ) major complication solid organ transplantation . The main reason AMR pre-formed , de-novo , donor specific antibody donor HLA antigen . Additional potential target antibodies MIC-A antigen antibody target express donor endothelial cell . Until recently , specific mean available test presence donor-specific endothelial cell antibody . The newly introduce XM-One AbSorber® assay allow isolate precursor endothelial cell donor peripheral blood , thus assess presence donor-specific endothelial cell antibody . XM-One AbSorber® in-vitro assay allow specific enrichment precursor endothelial cell turn promote endothelial cell specific cross match test . This assay currently use on-going Northwestern University ( NU ) research study ( STU # 00029988 ) . The preliminary result study indicate indeed patient test positive respective donor . One potential explanation observation , previously entertain , antibody cause positive cross match response actually autoimmune nature . In order rule-out potential explanation would like test patient perform autologous XM-One AbSorber® assay recipient serum incubate patient ' cell ( opposed respective donor cell parental study ) . This information crucial proper analysis data obtain NU STU # 00029988 study . Initial data laboratory indicate antigen identify XM-One Absorber® assay differ HLA antigens usually identify routine cross match assay . Moreover , able document polymorphic system therefore identify donor-specific source critical . Of 150 patient already study NU research protocol STU # 00029988 find 19 patient exhibit positive response donor-specific XM-One AbSorber® assay . In current research protocol study want follow-up specimen exhibit positive response donor-specific XM-One AbSorber® assay perform autologous XM-One AbSorber® assay validate clinical significance result . There one multicenter study report indicate `` XM-One AbSorber® quick , easy perform whole blood sample identify patient risk rejection reduce graft function identify conventional lymphocyte cross match '' The primary objective complete additional testing accuracy determine whether antibody direct donor-specific endothelial cell effect transplant outcome . The secondary objective ass frequency autologous antibody may falsely report donor-specific anti-endothelial antibody patient population . The single center research study Northwestern University work since May 19 , 2010 thus far result 19 150 specimen test , positive result base XM-One AbSorber® assay . In prospective study plan include XM-One AbSorber® positive test result recipients living-donor kidney transplant perform Northwestern Memorial Hospital ( NMH ) since May 19 , 2010 initial IRB approval 250 transplant perform . For research protocol target patient consent individual receive XM-One AbSorber® positive test result . Each donor / recipient pair require send peripheral blood sample HLA laboratory prior schedule transplant order perform lymphocyte cross match ( detect donor specific HLA antibody ; ( SOC ) standard care ) . Left serum cell test use isolate enrich precursor endothelial cell population perform XM-One AbSorber® assay ( NU research protocol # STU00029988 ) . XM-One AbSorber® assay result - autologous allogeneic - capture compare graft outcome measurement 3 , 6 , 12 month post-transplant . Transplant outcome record creatinine level specific time point , protocol for-cause biopsy result within first year post transplant , diagnosis acute cellular humoral rejection , variation immunosuppression level , complication . Patients exhibit positive XM-One AbSorber® allogeneic cross match result request donate 4 green top tube peripheral blood . Cells obtain blood use autologous XM-One AbSorber® cross match assay use original serum sample use allogeneic XM-One AbSorber® cross match assay .</detailed_description>
	<criteria>1. patient old 18 year age 2. patient undergoing livingdonor kidney transplant NMH positive XMOne AbSorber® positive test result 1. patient undergo deceased donor kidney transplant 2. patient young 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>renal</keyword>
	<keyword>kidney</keyword>
	<keyword>transplant</keyword>
	<keyword>live donor</keyword>
</DOC>